Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18602873 | EXPANDABLE FRAME FOR MEDICAL DEVICE | March 2024 | April 2025 | Allow | 13 | 2 | 0 | No | No |
| 18434290 | HEART VALVE THAT INCLUDES COATING MATERIAL | February 2024 | July 2025 | Allow | 17 | 3 | 0 | No | No |
| 17777203 | CUSTOMIZED GUIDE, AND APPARATUS AND METHOD FOR MANUFACTURING SAME | May 2022 | January 2026 | Abandon | 45 | 0 | 1 | No | No |
| 17691689 | Delivery System Radiopaque (RO) Markers For TAVR Commissure Alignment | March 2022 | August 2025 | Allow | 41 | 2 | 0 | Yes | No |
| 17589817 | Launcher for Introduction of A Medical Device | January 2022 | September 2025 | Abandon | 44 | 0 | 1 | No | No |
| 17577494 | METHOD USING CUSTOM PATIENT SPECIFIC IMPLANTS TO DECREASE THE NATURAL RATE OF AGING SITE SPECIFIC REGIONS OF THE FACIAL SKELETON | January 2022 | May 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17567616 | ARTIFICIAL ARTICULATION HAVING STABLE FIXING MEANS FOR UNICOMPARTMENTAL KNEE ARTHROPLASTY | January 2022 | February 2025 | Abandon | 37 | 2 | 0 | No | No |
| 17457278 | HAPTIC MANAGEMENT FOR DELIVERY OF INTRAOCULAR IMPLANTS | December 2021 | June 2025 | Allow | 42 | 2 | 0 | Yes | No |
| 17613512 | SLEEVE ELEMENT TO BE PLACED ON A NECK OF A PROSTHETIC HIP OR SHOULDER IMPLANT | November 2021 | February 2026 | Abandon | 51 | 3 | 0 | No | No |
| 17609231 | TEMPORARY SYNTHETIC CARRIER FOR CORNEAL TISSUE INSERTION AND TISSUE DELIVERY | November 2021 | June 2025 | Allow | 44 | 2 | 0 | No | No |
| 17496670 | METHOD OF ASSEMBLING A PROSTHETIC HEART VALVE | October 2021 | January 2025 | Allow | 39 | 1 | 0 | No | No |
| 17490931 | DEVICES AND METHODS FOR FIXATION AGAINST TISSUE | September 2021 | May 2024 | Allow | 32 | 2 | 0 | Yes | No |
| 17478764 | DELIVERY APPARATUS FOR A PROSTHETIC VALVE | September 2021 | June 2025 | Allow | 45 | 3 | 0 | Yes | No |
| 17466331 | COMMISSURE ATTACHMENT FOR PROSTHETIC HEART VALVE | September 2021 | June 2025 | Allow | 45 | 2 | 0 | Yes | Yes |
| 17432228 | GLENOID BASEPLATE AND IMPLANT ASSEMBLIES | August 2021 | April 2025 | Allow | 44 | 2 | 0 | No | No |
| 17397289 | HEART VALVE SEALING DEVICES AND DELIVERY DEVICES THEREFOR | August 2021 | October 2025 | Allow | 50 | 2 | 0 | Yes | No |
| 17428601 | Anchored Leaflet Device And Methods For Transcatheter Valve Repair | August 2021 | October 2024 | Abandon | 39 | 1 | 0 | No | No |
| 17390762 | GUIDE WIRE APPARATUSES AND METHODS | July 2021 | May 2025 | Allow | 45 | 1 | 0 | No | No |
| 17389332 | HEART VALVE PROSTHESIS | July 2021 | August 2025 | Allow | 49 | 2 | 0 | Yes | No |
| 17426921 | CAROTID ARTERY STENTING SYSTEMS AND METHODS | July 2021 | September 2025 | Allow | 49 | 3 | 0 | Yes | No |
| 17365418 | METHOD AND SYSTEM FOR PACKAGING AND PREPARING A PROSTHETIC HEART VALVE AND ASSOCIATED DELIVERY SYSTEM | July 2021 | March 2026 | Abandon | 56 | 3 | 0 | No | No |
| 17358445 | ADJUSTABLE BENDABLE SHEATH AND STENT DELIVERY DEVICE | June 2021 | May 2025 | Abandon | 46 | 2 | 0 | No | No |
| 17337711 | MECHANICALLY EXPANDABLE PROSTHETIC HEART VALVE AND DELIVERY APPARATUS | June 2021 | August 2024 | Allow | 38 | 1 | 0 | No | No |
| 17323259 | Heart Valve Repair Devices and Methods | May 2021 | June 2025 | Abandon | 49 | 1 | 0 | No | No |
| 17241577 | VALVE DIAMETER AND FORCE MONITORING OF A PROSTHETIC HEART VALVE | April 2021 | March 2025 | Allow | 47 | 2 | 1 | No | No |
| 17285867 | METHOD FOR USER-SIDE VOLUME ADAPTATION OF A BREAST PROSTHESIS | April 2021 | October 2024 | Abandon | 42 | 2 | 0 | No | No |
| 17284561 | Accommodative Functionality for Artificial Capsule Platform | April 2021 | May 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17284578 | Intraocular Artificial Lens Capsule | April 2021 | August 2025 | Allow | 52 | 4 | 0 | No | No |
| 17249755 | MEDICAL DEVICE DELIVERY | March 2021 | August 2025 | Allow | 53 | 4 | 0 | Yes | No |
| 17195249 | METHODS OF DELIVERING A FLEXIBLE ANNULOPLASTY RING | March 2021 | March 2026 | Allow | 60 | 2 | 0 | No | No |
| 17268034 | RELEASABLE KNOTS FOR MEDICAL DEVICE DELIVERY | February 2021 | October 2025 | Allow | 56 | 4 | 0 | Yes | No |
| 17155444 | INTERNAL BRACE FOR TISSUE REPAIRS AND REINFORCEMENTS | January 2021 | November 2024 | Abandon | 46 | 2 | 0 | No | No |
| 17104422 | Intraocular Device Responsive to Commands | November 2020 | September 2025 | Abandon | 58 | 4 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WHITE, KIA XIONG.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 100.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner WHITE, KIA XIONG works in Art Unit 3774 and has examined 26 patent applications in our dataset. With an allowance rate of 65.4%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 46 months.
Examiner WHITE, KIA XIONG's allowance rate of 65.4% places them in the 26% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by WHITE, KIA XIONG receive 2.23 office actions before reaching final disposition. This places the examiner in the 62% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by WHITE, KIA XIONG is 46 months. This places the examiner in the 11% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +52.9% benefit to allowance rate for applications examined by WHITE, KIA XIONG. This interview benefit is in the 94% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 35.0% of applications are subsequently allowed. This success rate is in the 78% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 46.2% of cases where such amendments are filed. This entry rate is in the 70% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 22% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 48% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.